JPRN-UMIN000029818已完成未知
Intravitreal triamcinolone acetonide combined withccataract surgery for diabetic macular edema - IVTA with cataract for DME
Department of Ophthalmology, Mie University Graduate School of Medicine0 个研究点目标入组 30 人开始时间: 2017年11月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients were excluded if they had the macular traction syndrome, active proliferative diabetic retinopathy, uveitis, poorly controlled ocular hypertension, glaucoma, had intraocular surgery within the past 6 months, and history of anti-VEGF treatment or STTA, or had macular photocoagulation within the past 3 months before the beginning of the treatment. Patients who had adverse reactions to steroids were also excluded.
研究者
相似试验
已完成
不适用
Intravitreal Injection of Triamcinolone Acetonide in RetinitisIRCT201104266293N1Tehran University of Medical Sciences161
已完成
不适用
Intravitreal versus subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular oedemaMacular oedemaEye DiseasesISRCTN67086909St Orsola Malpighi University Hospital Bologna (Italy)28
进行中（未招募）
不适用
Triamcinolone Acetonide Intravitreal Injection for the treatment for exudative maculopathy - NDexudative maculopathyMedDRA version: 8.1Level: LLTClassification code 10038862Term: Retinal exudatesEUCTR2006-001727-19-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
已完成
4 期
The Use of Intravitreal Injection of Triamcinolone Acetonide in Diabetic Patients to Reduce Diabetic Macular EdemaDiabetic macular edemaEye - Diseases / disorders of the eyeACTRN12613000249752suez canal university hospital19
已完成
2 期
Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema that Persists after Laser Treatment (TDMO)Diabetic Macular OedemaMetabolic and Endocrine - DiabetesEye - Diseases / disorders of the eyeACTRN12605000211662Professor Mark Gillies70